The therapeutic potential of mesenchymal stem cell-derived extracellular vesicles

被引：337

作者：

Katsuda, Takeshi ^{[1
]}

Kosaka, Nobuyoshi ^{[1
]}

Takeshita, Fumitaka ^{[1
]}

Ochiya, Takahiro ^{[1
]}

机构：

[1] Natl Canc Ctr, Div Mol & Cellular Med, Tokyo 1040045, Japan

来源：

PROTEOMICS | 2013年 / 13卷 / 10-11期

基金：

日本科学技术振兴机构;

关键词：

Cell biology; Exosome; Extracellular vesicle; Mesenchymal stem cells; Microvesicle; Therapeutics; MARROW STROMAL CELLS; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; HEPATIC FATE SPECIFICATION; EXOSOME-MEDIATED TRANSFER; UMBILICAL-CORD BLOOD; BONE-MARROW; IN-VITRO; ADIPOSE-TISSUE; RAT-LIVER; HEPATOGENIC DIFFERENTIATION;

D O I：

10.1002/pmic.201200373

中图分类号：

Q5 [生物化学];

学科分类号：

071010 ; 081704 ;

摘要：

Extracellular vesicles (EVs), membrane vesicles that are secreted by a variety of mammalian cell types, have been shown to play an important role in intercellular communication. The contents of EVs, including proteins, microRNAs, and mRNAs, vary according to the cell type that secreted them. Accordingly, researchers have demonstrated that EVs derived from various cell types play different roles in biological phenomena. Considering the ubiquitous presence of mesenchymal stem cells (MSCs) in the body, MSC-derived EVs may take part in a wide range of events. In particular, MSCs have recently attracted much attention due to the therapeutic effects of their secretory factors. MSC-derived EVs may therefore provide novel therapeutic approaches. In this review, we first summarize the wide range of functions of EVs released from different cell types, emphasizing that EVs echo the phenotype of their parent cell. Then, we describe the various therapeutic effects of MSCs and pay particular attention to the significance of their paracrine effect. We then survey recent reports on MSC-derived EVs and consider the therapeutic potential of MSC-derived EVs. Finally, we discuss remaining issues that must be addressed before realizing the practical application of MSC-derived EVs, and we provide some suggestions for enhancing their therapeutic efficiency.

引用

页码：1637 / 1653

页数：17

共 157 条

[1] Tumor exosomes expressing Fas ligand mediate CD8+ T-cell apoptosis [J].

Abusamra, AJ ;

Zhong, ZH ;

Zheng, XF ;

Li, M ;

Ichim, TE ;

Chin, JL ;

Min, WP .

BLOOD CELLS MOLECULES AND DISEASES, 2005, 35 (02) :169-173

[2] Functional studies of microRNAs in neural stem cells: problems and perspectives [J].

Akerblom, Mahn ;

Sachdeva, Rohit ;

Jakobsson, Johan .

FRONTIERS IN NEUROSCIENCE, 2012, 6

[3] Intercellular transfer of the oncogenic receptor EGFrvIII by microvesicles derived from tumour cells [J].

Al-Nedawi, Khalid ;

Meehan, Brian ;

Micallef, Johann ;

Lhotak, Vladimir ;

May, Linda ;

Guha, Abhijit ;

Rak, Janusz .

NATURE CELL BIOLOGY, 2008, 10 (05) :619-U24

[4] Endothelial expression of autocrine VEGF upon the uptake of tumor-derived microvesicles containing oncogenic EGFR [J].

Al-Nedawi, Khalid ;

Meehan, Brian ;

Kerbel, Robert S. ;

Allison, Anthony C. ;

Rak, Janusz .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2009, 106 (10) :3794-3799

[5] Diacylglycerol kinase α regulates the secretion of lethal exosomes bearing Fas ligand during activation-induced cell death of T lymphocytes [J].

Alonso, R ;

Rodríguez, MC ;

Pindado, J ;

Merino, E ;

Mérida, I ;

Izquierdo, M .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (31) :28439-28450

[6] Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes [J].

Alvarez-Erviti, Lydia ;

Seow, Yiqi ;

Yin, HaiFang ;

Betts, Corinne ;

Lakhal, Samira ;

Wood, Matthew J. A. .

NATURE BIOTECHNOLOGY, 2011, 29 (04) :341-U179

[7] TSAP6 facilitates the secretion of translationally controlled tumor protein/histamine-releasing factor via a nonclassical pathway [J].

Amzallag, N ;

Passer, BJ ;

Allanic, D ;

Segura, E ;

Théry, C ;

Goud, B ;

Amson, R ;

Telerman, A .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (44) :46104-46112

[8] Induction of lymphocyte apoptosis by tumor cell secretion of FasL-bearing microvesicles [J].

Andreola, G ;

Rivoltini, L ;

Castelli, C ;

Huber, V ;

Perego, P ;

Deho, P ;

Squarcina, P ;

Accornero, P ;

Lozupone, F ;

Lugini, L ;

Stringaro, A ;

Molinari, A ;

Arancia, G ;

Gentile, M ;

Parmiani, G ;

Fais, S .

JOURNAL OF EXPERIMENTAL MEDICINE, 2002, 195 (10) :1303-1316

[9] Functional integration of hepatocytes derived from human mesenchymal stem cells into mouse livers [J].

Aurich, Ines ;

Mueller, Lutz P. ;

Aurich, Hendryk ;

Luetzkendorf, Jana ;

Tisljar, Kai ;

Dollinger, Matthias M. ;

Schormann, Wiebke ;

Walldorf, Jens ;

Hengstler, Jan G. ;

Fleig, Wolfgang E. ;

Christ, Bruno .

GUT, 2007, 56 (03) :405-415

[10] IFATS Collection: In Vivo Therapeutic Potential of Human Adipose Tissue Mesenchymal Stem Cells After Transplantation into Mice with Liver Injury [J].

Banas, Agnieszka ;

Teratani, Takumi ;

Yamamoto, Yusuke ;

Tokuhara, Makoto ;

Takeshita, Fumitaka ;

Osaki, Mitsuhiko ;

Kawamata, Masaki ;

Kato, Takashi ;

Okochi, Hitoshi ;

Ochiya, Takahiro .

STEM CELLS, 2008, 26 (10) :2705-2712

← 1 2 3 4 5 6 7 8 9 10 →